Case Reports: Mimics of Polyarteritis Nodosa
When polyarteritis nodosa isn’t PAN: Two cases of mimics, segmental arterial mediolysis (SAM) & vascular Ehlers-Danlos syndrome (vEDS), are explored. […]
When polyarteritis nodosa isn’t PAN: Two cases of mimics, segmental arterial mediolysis (SAM) & vascular Ehlers-Danlos syndrome (vEDS), are explored. […]
APLAR 2025: What’s New in RA Management? aurelie.najm@g… Mon, 09/08/2025 – 08:15
Rheumatology. Published online August 29, 2025. doi:10.1093/rheumatology/keaf458. References. Soufla A, Papazoglou N, Sfikakis PP, Tektonidou MGÂ …
Systemic sclerosis (SSc) is an autoimmune disease in which fibrotic, vascular, autoimmune and fibrotic mechanisms synergize to promote disease …
QD Clinic: ILD, Emphysema, Both, or Neither? tammytilley@gm… Mon, 09/08/2025 – 08:00 Rheumatoid Arthritis Cardio/Pulmonary Dr. Janet Pope, London, Ontario
Addressing Disparities and Unequal Burdens in ILD deji@uchicago.edu Mon, 09/08/2025 – 08:00
Following numerous blood tests and the expertise of a rheumatology … In January this year, she found herself at the
She went to the hospital in January this year, where she was given an emergency appointment with a rheumatology specialist.
Staff profile for Professor Raza Karim, Professor of Clinical Rheumatology and Honorary Consultant, Department of Inflammation and Ageing, College of …
… Rheumatology, said point-of-care AI can help rheumatologists untangle difficult diagnoses. According to Calabrese, the task of diagnosing and …
Rheumatology (Oxford). 2025 Sep 8:keaf478. doi: 10.1093/rheumatology/keaf478. Online ahead of print. NO ABSTRACT PMID:40920420 | DOI:10.1093/rheumatology/keaf478
J Telemed Telecare. 2025 Sep 8:1357633X251372681. doi: 10.1177/1357633X251372681. Online ahead of print. ABSTRACT IntroductionTo investigate the effectiveness of the remote
Biomol Biomed. 2025 Sep 8. doi: 10.17305/bb.2025.12919. Online ahead of print. ABSTRACT Rheumatoid arthritis (RA) is a chronic autoimmune disease
Adv Ther. 2025 Sep 8. doi: 10.1007/s12325-025-03299-0. Online ahead of print. ABSTRACT BACKGROUND AND OBJECTIVES: Deucravacitinib, a first-in-class, oral, selective,
Rheumatol Int. 2025 Sep 8;45(9):222. doi: 10.1007/s00296-025-05978-1. ABSTRACT The Impact of Obesity and Overweight on Rheumatoid Arthritis Patients: Real-World Insights
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07664-1. Online ahead of print. ABSTRACT Medications like liraglutide 3.0 mg daily (Saxenda®; Novo
Clin Hemorheol Microcirc. 2025 Sep 8:13860291251375286. doi: 10.1177/13860291251375286. Online ahead of print. ABSTRACT ObjectivesThis study investigated haemorheological alterations in patients
Clin Exp Rheumatol. 2025 Sep 5. doi: 10.55563/clinexprheumatol/v0g0cd. Online ahead of print. NO ABSTRACT PMID:40920065 | DOI:10.55563/clinexprheumatol/v0g0cd
Pediatr Crit Care Med. 2025 Sep 8. doi: 10.1097/PCC.0000000000003826. Online ahead of print. ABSTRACT OBJECTIVES: To investigate whether the urine
Am J Hematol. 2025 Sep 8. doi: 10.1002/ajh.70061. Online ahead of print. ABSTRACT Loss of function mutations in the gene
Front Mol Biosci. 2025 Aug 22;12:1632244. doi: 10.3389/fmolb.2025.1632244. eCollection 2025. ABSTRACT BACKGROUND: The clinical differentiation between obstetric antiphospholipid syndrome (OAPS)
Open Access Rheumatol. 2025 Aug 31;17:185-191. doi: 10.2147/OARRR.S500619. eCollection 2025. ABSTRACT OBJECTIVE: To evaluate the efficacy of baricitinib in combination
Biologics. 2025 Aug 30;19:525-538. doi: 10.2147/BTT.S532668. eCollection 2025. ABSTRACT OBJECTIVE: We aim to evaluate the malignancy risk between Janus kinase
Front Microbiol. 2025 Aug 22;16:1640149. doi: 10.3389/fmicb.2025.1640149. eCollection 2025. ABSTRACT Autism spectrum disorders (ASD), a group of neurodevelopmental disorders characterized
Front Surg. 2025 Aug 21;12:1557431. doi: 10.3389/fsurg.2025.1557431. eCollection 2025. ABSTRACT BACKGROUND: In recent years, global cholecyst-related disorders have been increasing
Cell Physiol Biochem. 2025 Sep 1;59(5):557-568. doi: 10.33594/000000808. ABSTRACT BACKGROUND/AIMS: Ubiquitin D (UBD), a member of the ubiquitin-like modifier (UBL)
Clin Exp Immunol. 2025 Sep 6:uxaf050. doi: 10.1093/cei/uxaf050. Online ahead of print. ABSTRACT INTRODUCTION: Immunosenescence remodels immune functions and was